Tirzepatide, a innovative medication, is creating significant excitement in the scientific community as a viable treatment for both type 2 diabetes and body composition . This dual-action drug works by targeting two distinct receptors, GLP-1 and GIP, leading to better blood sugar levels and significant slimming in testing. While initial data are en